Celgene International Sárl Release: First-Of-Its-Kind Multinational Survey Confirms Psoriasis And Psoriatic Arthritis Patients Are Frequently Undertreated Or Not Treated At All

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOUDRY, Switzerland--(BUSINESS WIRE)--A unique and extensive survey provides the first-of-its-kind multinational look into the impact psoriasis and psoriatic arthritis (PsA) have on patients’ lives, revealing several areas which warrant further attention and action, including high rates of undertreatment, a mismatch between patient/physician assessment of the disease, and the desire for new treatment options.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC